ZA857595B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA857595B ZA857595B ZA857595A ZA857595A ZA857595B ZA 857595 B ZA857595 B ZA 857595B ZA 857595 A ZA857595 A ZA 857595A ZA 857595 A ZA857595 A ZA 857595A ZA 857595 B ZA857595 B ZA 857595B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848424957A GB8424957D0 (en) | 1984-10-03 | 1984-10-03 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA857595B true ZA857595B (en) | 1986-05-28 |
Family
ID=10567622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA857595A ZA857595B (en) | 1984-10-03 | 1985-10-02 | Pharmaceutical compositions |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU583539B2 (en) |
CA (1) | CA1266002A (en) |
GB (1) | GB8424957D0 (en) |
ZA (1) | ZA857595B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA702518B (en) * | 1969-04-18 | 1971-01-27 | Bristol Myers Co | Acetylcysteine for acne |
AU8048882A (en) * | 1981-03-05 | 1982-09-09 | National Foundation For Cancer Research Inc. | Adducts of glyoxal and cysteine as antitumor agents |
-
1984
- 1984-10-03 GB GB848424957A patent/GB8424957D0/en active Pending
-
1985
- 1985-10-02 CA CA000492037A patent/CA1266002A/en not_active Expired
- 1985-10-02 AU AU48207/85A patent/AU583539B2/en not_active Ceased
- 1985-10-02 ZA ZA857595A patent/ZA857595B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU4820785A (en) | 1986-04-10 |
AU583539B2 (en) | 1989-05-04 |
CA1266002A (en) | 1990-02-20 |
GB8424957D0 (en) | 1984-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8508452D0 (en) | Pharmaceutical compositions | |
GB8403359D0 (en) | Pharmaceutical compositions | |
GB8426672D0 (en) | Pharmaceutical compositions | |
EP0163178A3 (en) | Pharmaceutical composition | |
GB2165451B (en) | Pharmaceutical compositions | |
GB8410290D0 (en) | Pharmaceutical compositions | |
GB8410289D0 (en) | Pharmaceutical compositions | |
GB8403360D0 (en) | Pharmaceutical compositions | |
GB8503513D0 (en) | Pharmaceutical compositions | |
GB8409961D0 (en) | Pharmaceutical compositions | |
GB2153676B (en) | Pharmaceutical composition | |
GB8524054D0 (en) | Pharmaceutical compositions | |
CY1980A (en) | Pharmaceutical compositions | |
GB8427877D0 (en) | Pharmaceutical compositions | |
GB8426151D0 (en) | Pharmaceutical compositions | |
GB8424957D0 (en) | Pharmaceutical compositions | |
IE69569L (en) | Pharmaceutical compositions | |
IE842522L (en) | Pharmaceutical compositions | |
ZA84895B (en) | Pharmaceutical compositions | |
GB8419244D0 (en) | Pharmaceutical compositions | |
GB8416437D0 (en) | Pharmaceutical compositions | |
GB8411116D0 (en) | Pharmaceutical compositions | |
GB8431899D0 (en) | Pharmaceutical compositions | |
GB8427486D0 (en) | Pharmaceutical compositions | |
GB8426375D0 (en) | Pharmaceutical compositions |